{
    "1671399590015250433": {
        "attachments": {
            "media_keys": [
                "3_1671399578917019648"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-06-21T06:08:10.000Z",
        "edit_history_tweet_ids": [
            "1671399590015250433"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 69,
                    "normalized_text": "RSV",
                    "probability": 0.645,
                    "start": 67,
                    "type": "Other"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.to/449XuM1",
                    "end": 119,
                    "expanded_url": "https://gsk.to/449XuM1",
                    "start": 96,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/media/press-releases/?linkId=100000206306842",
                    "url": "https://t.co/uuhdvjUurD"
                },
                {
                    "display_url": "pic.twitter.com/pB543KVB1P",
                    "end": 143,
                    "expanded_url": "https://twitter.com/GSK/status/1671399590015250433/photo/1",
                    "media_key": "3_1671399578917019648",
                    "start": 120,
                    "url": "https://t.co/pB543KVB1P"
                }
            ]
        },
        "id": "1671399590015250433",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 5868,
            "like_count": 9,
            "quote_count": 1,
            "reply_count": 1,
            "retweet_count": 1
        },
        "text": "News for investors and media: Today we have shared new data on our RSV vaccine. \n\nFind out more https://t.co/uuhdvjUurD https://t.co/pB543KVB1P"
    }
}